Drugs / AMI MultiStem cells
last change Jan 2020 re-read 3 minutes ago

AMI MultiStem cells

also known as AMI MultiStem
Developed for
myocardial infarction
Investigated by
Healios K.K. · National Heart, Lung, and Blood Institute (NHLBI)

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02277613 Dec 2015 → Jun 2019 myocardial infarction Healios K.K. Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AMI MultiStem cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT02277613 ↗
Known as AMI MultiStem “A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction” NCT02277613 ↗